Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 03, 2012 08:00 ET | Source: Novavax, Inc.

NOVAVAX Reports Progress Under Joint Venture in India With Cadila Pharmaceuticals

Regulatory approval received for rabies vaccine toxicology studies in India Clinical study of influenza vaccine candidate planned for 2012 Validated manufacturing facility ready for...
November 28, 2011 12:17 ET | Source: Novavax, Inc.

NOVAVAX to Present at 23rd Annual Piper Jaffray Health Care Conference

ROCKVILLE, Md., Nov. 28, 2011 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) a clinical-stage vaccine company, announced today that Stanley C. Erck, President and Chief Executive Officer of Novavax,...
November 21, 2011 20:03 ET | Source: Novavax, Inc.

NOVAVAX Acquires New Manufacturing and Office Facilities in Gaithersburg, MD

ROCKVILLE, Md., Nov. 21, 2011 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced that it has entered a long-term lease arrangement for 74,000-square-feet of manufacturing, lab and office...
November 10, 2011 08:00 ET | Source: Novavax, Inc.

NOVAVAX to Present at the Lazard Capital Markets 8th Annual Healthcare Conference

ROCKVILLE, Md., Nov. 10, 2011 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) a clinical-stage vaccine company, announced today that Frederick W. Driscoll, Vice President and Chief Financial Officer...
November 07, 2011 08:00 ET | Source: Novavax, Inc.

NOVAVAX Appoints Russell "Rip" Wilson Senior Vice President of Business Development

ROCKVILLE, Md., Nov. 7, 2011 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) announced today the appointment of Russell P. "Rip" Wilson as Senior Vice President of Business Development. Mr. Wilson...
November 04, 2011 08:00 ET | Source: Novavax, Inc.

NOVAVAX Reports Third Quarter 2011 Financial Results

ROCKVILLE, Md., Nov. 4, 2011 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced financial results for the third quarter ended September 30, 2011. Novavax reported a net loss of $3.2...
November 03, 2011 16:28 ET | Source: Novavax, Inc.

NOVAVAX Appoints Erica S. Shane, Ph.D., Vice President, Process Development

ROCKVILLE, Md., Nov. 3, 2011 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) announced today the appointment of Erica Shane, Ph.D., to the position of Vice President, Process Development. In this...
October 28, 2011 08:00 ET | Source: Novavax, Inc.

NOVAVAX to Report Third Quarter 2011 Financial Results on November 4, 2011

ROCKVILLE, Md., Oct. 28, 2011 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) will report financial results for the third fiscal quarter of 2011 on Friday, November 4, 2011, before the U.S. financial...
October 27, 2011 14:27 ET | Source: Novavax, Inc.

NOVAVAX CEO Addresses U.S. Patent and Trademark Office (USPTO) on Behalf of the Biotechnology Industry Organization (BIO)

ROCKVILLE, Md., Oct. 27, 2011 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced that Stanley C. Erck, President and Chief Executive Officer of Novavax, testified this afternoon on behalf...
October 10, 2011 09:56 ET | Source: Novavax, Inc.

NOVAVAX Announces Conference Call to Discuss Results From Phase I Trial of Respiratory Syncytial Virus Vaccine Candidate

ROCKVILLE, Md., Oct. 10, 2011 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced that it will conduct a conference call for invited analysts and institutional investors on October 13,...